Skip to main content
. 2023 Apr 10;21:252. doi: 10.1186/s12967-023-04072-z

Table 1.

Clinical and demographic characteristics of the analyzed sample

Level Non-exposed Exposed p value
n 1129 1129
Female (%) 574 (50.8) 574 (50.8) 1.000
Age (%)
 < 45 yr 783 (69.4) 783 (69.4) 1.000
 45-65 yr 248 (22.0) 248 (22.0)
 > 65 yr 98 (8.7) 98 (8.7)
Race (%)
 Black 319 (28.3) 319 (28.3) 1.000
 Other 31 (2.7) 31 (2.7)
 White 779 (69.0) 779 (69.0)
PIR (mean (SD)) 2.86 (1.82) 2.84 (1.83) 0.778
Smokers (%) 561 (49.7) 596 (52.8) 0.152
BMI (%)
 Underweight 47 (4.2) 6 (0.5)  < 0.001
 Normal 766 (67.9) 266 (23.6)
 Overweight 299 (26.5) 434 (38.4)
 Obese 16 (1.4) 423 (37.5)
No. Of MetS factors (%)
 0 1129 (100.0) 0 (0.0)  < 0.001
 1 0 (0.0) 441 (39.1)
 2 0 (0.0) 318 (28.2)
 3 0 (0.0) 206 (18.2)
 4 0 (0.0) 109 (9.7)
 5 0 (0.0) 55 (4.9)
Increased WC (%) 0 (0.0) 628 (55.6)  < 0.001
High TG (%) 0 (0.0) 429 (38.0)  < 0.001
Low HDL (%) 0 (0.0) 566 (50.1)  < 0.001
High BP (%) 0 (0.0) 406 (36.0)  < 0.001
High glucose (%) 0 (0.0) 377 (33.4)  < 0.001
Periodontitis (%) 222 (19.7) 259 (22.9) 0.064
Periodontal status (%)
 Healthy 705 (62.4) 610 (54.0)  < 0.001
 Gingivitis 202 (17.9) 260 (23.0)
 Stable periodontitis 143 (12.7) 137 (12.1)
 Active periodontitis 79 (7.0) 122 (10.8)
PISA (mean (SD)) 30.36 (61.21) 43.17 (79.81)  < 0.001
PPD (mean (SD)) 2.35 (0.45) 2.43 (0.50)  < 0.001
CAL (mean (SD)) 2.03 (0.91) 2.08 (0.90) 0.220
BoP (mean (SD)) 7.44 (12.61) 10.13 (15.06)  < 0.001
Gingival bleeding (%)
 No BoP 596 (52.8) 517 (45.8)  < 0.001
 BoP < 10% 252 (22.3) 230 (20.4)
 BoP ≥ 10% 281 (24.9) 382 (33.8)
Diabetics (%) 0 (0.0) 74 (6.6)  < 0.001
Diabetics on insulin (%) 0 (0.0) 19 (28.8)  < 0.001
SBP (mean (SD)) 115.53 (12.76) 124.29 (16.63)  < 0.001
DBP (mean (SD)) 71.83 (8.14) 77.73 (10.25)  < 0.001
Hypertensives (%) 0 (0.0) 328 (29.2)  < 0.001
Hypertensives on HT pills (%) 0 (0.0) 158 (76.3)  < 0.001
BP ≥ 130/80 mmHg 280 (24.8) 570 (50.5)  < 0.001
BP ≥ 140/90 mmHg 55 (4.9) 239 (21.2)  < 0.001
HbA1c (%)
 Normal 1023 (91.0) 851 (75.7)  < 0.001
 Pre-diabetes 99 (8.8) 188 (16.7)
 Diabetes 2 (0.2) 85 (7.6)
WBC (mean (SD)) 6.72 (2.01) 7.26 (2.20)  < 0.001
Lymphocytes (mean (SD)) 2.16 (0.65) 2.35 (0.90)  < 0.001
Monocytes (mean (SD)) 0.38 (0.18) 0.42 (0.21)  < 0.001
Granulocytes (mean (SD)) 4.18 (1.65) 4.49 (1.77)  < 0.001
RBC (mean (SD)) 4.62 (0.46) 4.73 (0.48)  < 0.001
Hb (mean (SD)) 13.96 (1.41) 14.10 (1.53) 0.021
HTC (mean (SD)) 41.42 (3.89) 41.76 (4.15) 0.047
PLT (mean (SD)) 262.51 (63.12) 274.01 (72.93)  < 0.001
Ferritin (mean (SD)) 113.32 (119.85) 145.10 (150.36)  < 0.001
LDL-c (mean (SD)) 117.59 (32.28) 129.59 (33.99)  < 0.001
HDL-c (mean (SD)) 60.81 (14.27) 47.27 (14.89)  < 0.001
CRP (mean (SD)) 0.30 (0.43) 0.49 (0.99)  < 0.001
Glucose (mean (SD)) 87.03 (7.18) 101.25 (35.55)  < 0.001
Creatinine (mean (SD)) 1.06 (0.18) 1.07 (0.22) 0.068
Cholesterol (mean (SD)) 199.25 (36.22) 210.57 (40.85)  < 0.001
Triglycerides (mean (SD)) 80.67 (27.73) 153.61 (110.03)  < 0.001

Individuals in the exposed group have at least one MetS component, while non-exposed individuals have none

BMI Body Mass Index, HbA1c glycated hemoglobin, PISA periodontal inflamed surface area, PPD periodontal pocket depth, CAL clinical attachment loss, BoP bleeding on probing, WBC white blood cells, RBC red blood cells, Hb hemoglobin, HCT hematocrit, PLT platelets, LDL-c low density lipoprotein cholesterol, HDL-c high density lipoprotein cholesterol, CRP C-reactive protein, SBP systolic blood pressure, DBP diastolic blood pressure, HT hypertension